Inhaled budesonide for early treatment of COVID-19

Lancet Respir Med. 2021 Jul;9(7):e60. doi: 10.1016/S2213-2600(21)00217-4. Epub 2021 May 12.

Authors

Jae Chol Choi¹, Won-Young Kim²

Affiliations

¹ Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Dongjak-gu, Seoul 06973, South Korea.
² Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Dongjak-gu, Seoul 06973, South Korea. Electronic address: wykim81@cau.ac.kr.

No abstract available

Publication types

Letter
Comment

MeSH terms

Administration, Inhalation
Bronchodilator Agents / therapeutic use
Budesonide*
COVID-19*
Humans
SARS-CoV-2

Substances

Bronchodilator Agents
Budesonide